Difference between revisions of "Thrombotic microangiopathy"
Jump to navigation
Jump to search
m (tweak refs) |
(more) |
||
Line 4: | Line 4: | ||
*[[Hemolytic uremic syndrome]]. | *[[Hemolytic uremic syndrome]]. | ||
*[[Thrombotic thrombocytopenic purpura]] (TTP). | *[[Thrombotic thrombocytopenic purpura]] (TTP). | ||
Others: | |||
*[[Malignant hypertension]]. | |||
*[[DIC]]. | |||
*[[APLA]] in [[SLE]]. | |||
*Scleroderma renal crisis. | |||
*HIV associated TTP. | |||
*Chemotherapy. | |||
*Calcineurin inhibitor toxicity. | |||
==Microscopic== | ==Microscopic== |
Revision as of 21:33, 29 October 2011
Thrombotic microangiopathy is a group of disorders affecting small blood vessels. Microangiopathic is a disease affecting small blood vessels.[1]
Others:
- Malignant hypertension.
- DIC.
- APLA in SLE.
- Scleroderma renal crisis.
- HIV associated TTP.
- Chemotherapy.
- Calcineurin inhibitor toxicity.
Microscopic
Features:[4]
- Microvascular occlusion.[5]
- "Loose" intimal thickening; fluffy appearing intima.
- Fibrin entrapped RBCs.
Notes:
- Microvascular occlusion is non-specific -- also seen in DIC.
- The last two (#2 and #3) are useful for discrimination from endarteritis.[4]
See also
References
- ↑ URL: http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/one/000005089.htm. Accessed on: 9 September 2010.
- ↑ URL: http://emedicine.medscape.com/article/779218-overview. Accessed on: 8 November 2010.
- ↑ Mayer SA, Aledort LM (May 2005). "Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies". Mt. Sinai J. Med. 72 (3): 166–75. PMID 15915311.
- ↑ 4.0 4.1 Fogo, Agnes; Bruijn, Jan A.; Cohen, Arthur H.; Colvin, Robert B.;Jennette, J. Charles (2006). Fundamentals of Renal Pathology (1st ed.). Springer. pp. 204. ISBN 978-0387311265.
- ↑ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 670. ISBN 978-1416031215.